CN112841310A - Newborn formula liquid milk and preparation method thereof - Google Patents
Newborn formula liquid milk and preparation method thereof Download PDFInfo
- Publication number
- CN112841310A CN112841310A CN201911098503.6A CN201911098503A CN112841310A CN 112841310 A CN112841310 A CN 112841310A CN 201911098503 A CN201911098503 A CN 201911098503A CN 112841310 A CN112841310 A CN 112841310A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- milk
- newborn
- liquid milk
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013336 milk Nutrition 0.000 title claims abstract description 73
- 239000008267 milk Substances 0.000 title claims abstract description 73
- 210000004080 milk Anatomy 0.000 title claims abstract description 73
- 239000007788 liquid Substances 0.000 title claims abstract description 69
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 150000001875 compounds Chemical class 0.000 claims abstract description 37
- 239000000843 powder Substances 0.000 claims abstract description 33
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 31
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 31
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 23
- -1 fatty acid ester Chemical class 0.000 claims abstract description 19
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 18
- 239000008158 vegetable oil Substances 0.000 claims abstract description 18
- 235000021119 whey protein Nutrition 0.000 claims abstract description 18
- 235000012716 cod liver oil Nutrition 0.000 claims abstract description 17
- 239000003026 cod liver oil Substances 0.000 claims abstract description 17
- 239000002773 nucleotide Substances 0.000 claims abstract description 17
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 17
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 16
- 239000011707 mineral Substances 0.000 claims abstract description 16
- 229940088594 vitamin Drugs 0.000 claims abstract description 16
- 229930003231 vitamin Natural products 0.000 claims abstract description 16
- 235000013343 vitamin Nutrition 0.000 claims abstract description 16
- 239000011782 vitamin Substances 0.000 claims abstract description 16
- 102000010445 Lactoferrin Human genes 0.000 claims abstract description 15
- 108010063045 Lactoferrin Proteins 0.000 claims abstract description 15
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 15
- 235000021242 lactoferrin Nutrition 0.000 claims abstract description 15
- 229940078795 lactoferrin Drugs 0.000 claims abstract description 15
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims abstract description 14
- 235000013734 beta-carotene Nutrition 0.000 claims abstract description 14
- 239000011648 beta-carotene Substances 0.000 claims abstract description 14
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims abstract description 14
- 229960002747 betacarotene Drugs 0.000 claims abstract description 14
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 14
- 229930195729 fatty acid Natural products 0.000 claims abstract description 14
- 239000000194 fatty acid Substances 0.000 claims abstract description 14
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims abstract description 14
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims abstract description 13
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 13
- 239000005862 Whey Substances 0.000 claims abstract description 13
- 239000008101 lactose Substances 0.000 claims abstract description 13
- 229940083466 soybean lecithin Drugs 0.000 claims abstract description 13
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000020185 raw untreated milk Nutrition 0.000 claims description 25
- 239000004615 ingredient Substances 0.000 claims description 13
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 12
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 12
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 12
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 11
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 11
- 229930003316 Vitamin D Natural products 0.000 claims description 11
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 11
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 11
- 235000019155 vitamin A Nutrition 0.000 claims description 11
- 239000011719 vitamin A Substances 0.000 claims description 11
- 235000019166 vitamin D Nutrition 0.000 claims description 11
- 239000011710 vitamin D Substances 0.000 claims description 11
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 11
- 229940045997 vitamin a Drugs 0.000 claims description 11
- 229940046008 vitamin d Drugs 0.000 claims description 11
- 238000000265 homogenisation Methods 0.000 claims description 10
- 238000004659 sterilization and disinfection Methods 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 6
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 claims description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- AANLCWYVVNBGEE-IDIVVRGQSA-L Disodium inosinate Chemical compound [Na+].[Na+].O[C@@H]1[C@H](O)[C@@H](COP([O-])([O-])=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 AANLCWYVVNBGEE-IDIVVRGQSA-L 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 6
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 6
- 235000019482 Palm oil Nutrition 0.000 claims description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- 229930003427 Vitamin E Natural products 0.000 claims description 6
- 229930003448 Vitamin K Natural products 0.000 claims description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 6
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims description 6
- 229950006790 adenosine phosphate Drugs 0.000 claims description 6
- 229960002685 biotin Drugs 0.000 claims description 6
- 235000020958 biotin Nutrition 0.000 claims description 6
- 239000011616 biotin Substances 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 229960004203 carnitine Drugs 0.000 claims description 6
- 239000000460 chlorine Substances 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 229910052802 copper Inorganic materials 0.000 claims description 6
- 239000010949 copper Substances 0.000 claims description 6
- 235000005687 corn oil Nutrition 0.000 claims description 6
- 239000002285 corn oil Substances 0.000 claims description 6
- 235000013890 disodium inosinate Nutrition 0.000 claims description 6
- KURVIXMFFSNONZ-WFIJOQBCSA-L disodium;[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound [Na+].[Na+].O[C@@H]1[C@H](O)[C@@H](COP([O-])([O-])=O)O[C@H]1N1C(=O)NC(=O)C=C1 KURVIXMFFSNONZ-WFIJOQBCSA-L 0.000 claims description 6
- 229960000304 folic acid Drugs 0.000 claims description 6
- 235000019152 folic acid Nutrition 0.000 claims description 6
- 239000011724 folic acid Substances 0.000 claims description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 6
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 6
- 229910052742 iron Inorganic materials 0.000 claims description 6
- 239000000944 linseed oil Substances 0.000 claims description 6
- 235000021388 linseed oil Nutrition 0.000 claims description 6
- 239000011777 magnesium Substances 0.000 claims description 6
- 229910052749 magnesium Inorganic materials 0.000 claims description 6
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000002540 palm oil Substances 0.000 claims description 6
- 229940055726 pantothenic acid Drugs 0.000 claims description 6
- 235000019161 pantothenic acid Nutrition 0.000 claims description 6
- 239000011713 pantothenic acid Substances 0.000 claims description 6
- 239000011574 phosphorus Substances 0.000 claims description 6
- 229910052698 phosphorus Inorganic materials 0.000 claims description 6
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 6
- 239000011591 potassium Substances 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 6
- 239000011669 selenium Substances 0.000 claims description 6
- 229910052711 selenium Inorganic materials 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 239000003549 soybean oil Substances 0.000 claims description 6
- 235000012424 soybean oil Nutrition 0.000 claims description 6
- 239000011691 vitamin B1 Substances 0.000 claims description 6
- 239000011715 vitamin B12 Substances 0.000 claims description 6
- 239000011716 vitamin B2 Substances 0.000 claims description 6
- 239000011726 vitamin B6 Substances 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- 235000019165 vitamin E Nutrition 0.000 claims description 6
- 239000011709 vitamin E Substances 0.000 claims description 6
- 229940046009 vitamin E Drugs 0.000 claims description 6
- 235000019168 vitamin K Nutrition 0.000 claims description 6
- 239000011712 vitamin K Substances 0.000 claims description 6
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 6
- 229940046010 vitamin k Drugs 0.000 claims description 6
- 239000011701 zinc Substances 0.000 claims description 6
- 229910052725 zinc Inorganic materials 0.000 claims description 6
- 239000005018 casein Substances 0.000 claims description 5
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 5
- 235000021240 caseins Nutrition 0.000 claims description 5
- PVBRXXAAPNGWGE-LGVAUZIVSA-L disodium 5'-guanylate Chemical compound [Na+].[Na+].C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP([O-])([O-])=O)[C@@H](O)[C@H]1O PVBRXXAAPNGWGE-LGVAUZIVSA-L 0.000 claims description 5
- 239000004193 disodium 5'-ribonucleotide Substances 0.000 claims description 5
- 235000013896 disodium guanylate Nutrition 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000003921 oil Substances 0.000 claims description 5
- 235000019198 oils Nutrition 0.000 claims description 5
- 235000020238 sunflower seed Nutrition 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 3
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000011570 nicotinamide Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 2
- 235000019486 Sunflower oil Nutrition 0.000 claims 1
- 239000002600 sunflower oil Substances 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 235000013350 formula milk Nutrition 0.000 abstract description 65
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 abstract description 8
- 235000013305 food Nutrition 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 2
- 235000020247 cow milk Nutrition 0.000 abstract 1
- 230000033764 rhythmic process Effects 0.000 abstract 1
- 230000001953 sensory effect Effects 0.000 description 29
- 238000011156 evaluation Methods 0.000 description 14
- 238000003860 storage Methods 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 230000001079 digestive effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000030363 nerve development Effects 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
- A23C9/1512—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins containing isolated milk or whey proteins, caseinates or cheese; Enrichment of milk products with milk proteins in isolated or concentrated form, e.g. ultrafiltration retentate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A newborn formula liquid milk and a preparation method thereof belong to the technical field of newborn formula food processing. In order to solve the problems of troublesome reconstitution, inconvenient carrying when people go out, non-uniform concentration, potential health and safety hazards and the like of the traditional newborn formula milk powder, the invention provides newborn formula liquid milk which is prepared from cow milk, skim milk, compound vegetable oil whey protein powder, desalted whey powder, lactose, compound vitamins, compound minerals, nucleotides, lactoferrin, beta-carotene, cod liver oil, soybean lecithin, monoglyceride and diglyceride fatty acid ester and water; the dry matter content of the newborn formula liquid milk is 10-15%. The newborn formula liquid milk provided by the invention does not need to be mixed, is uniform in concentration, safe and sanitary, is convenient to carry when going out, and is more in line with the modern life rhythm.
Description
Technical Field
The invention relates to a newborn formula liquid milk and a preparation method thereof, belonging to the technical field of newborn formula food processing.
Background
The newborn baby is a baby from the birth of the fetus to the 28 th postnatal day after umbilical cord ligation, and is a special stage of the infancy stage due to obvious particularity in growth, development, diseases and the like, such as the fastest growth and development speed, high morbidity and mortality and the like in the stage. The ratio of whey protein to milk casein varies between the neonatal period and the infant period, and the fatty acid pattern also varies greatly, so that the feeding of the newborn is important. However, in the case of no breast milk, insufficient breast milk or incapability of breast feeding due to the physical condition of the mother, the newborn formula liquid milk is particularly important for the newborn.
Infant formula liquid milk is internationally recognized as one of the most advanced infant formula at present, represents a brand new feeding concept, is highly concerned by the industry since the market, but is relatively strange for most parents. Foreign enterprises such as the minister of Meizan, the Yapei, the love of Taimei, the cowshed and the like have own brands of infant formula liquid milk for a long time, and have been produced and sold for more than ten years, but domestic consumers have little knowledge of the brands. Currently, infant formula liquid milk is being produced and sold in many countries around the world, such as the united states, finland, etc., which are becoming new players in the infant formula market. At present, infant formula milk powder is mainly used in the market, and the development of formula liquid milk is in the initial stage.
The newborn formula liquid milk is a new pet in the infant formula food market, and mainly has the advantages that the newborn formula liquid milk does not need to be brewed, a lot of time is saved, the newborn formula liquid milk is attractive to office workers, the concentration of the reconstituted infant formula milk powder is uniform, feeding is convenient, the newborn formula liquid milk is suitable for being carried out, and the newborn formula liquid milk is safe and sanitary and is more beneficial to healthy growth of the newborn.
Therefore, the research and development of the liquid milk formula for the newborn is vital to the newborn stage with high morbidity and mortality and high growth and development speed, and the invention provides theoretical basis for production and technical guidance for production.
Disclosure of Invention
In order to solve the problems of troublesome reconstitution, inconvenient carrying, non-uniform concentration, potential health and safety hazards and the like of the traditional newborn formula milk powder, the invention provides a newborn formula liquid milk and a preparation method thereof, and the adopted technical scheme is as follows:
the invention aims to provide a newborn formula liquid milk, wherein each 1000L of the newborn formula liquid milk comprises the following components: 114.4-220.3 kg of raw milk, 39.16-114.4 kg of skim milk, 25.81-29.7 kg of compound vegetable oil, 6.5-7.5 kg of whey protein powder, 58.5-65 kg of desalted whey powder, 13.67-22.5 kg of lactose, 0.14-0.25 kg of compound vitamin, 0.2-0.5 kg of compound mineral, 0.09-0.1 kg of nucleotide, 0.05-0.13 kg of lactoferrin, 0.000375-0.0005 kg of beta-carotene, 2.8-3L of cod liver oil, 0.5-0.52 kg of soybean lecithin and 0.3-0.5 kg of mono-diglycerol fatty acid ester; the dry matter content of the newborn formula liquid milk is 10-15%.
Further defined, the compounded vegetable oil consists of soybean oil, corn oil, palm oil, linseed oil and sunflower seed oil; wherein the mass ratio of the soybean oil to the corn oil to the palm oil to the linseed oil to the sunflower seed oil is 6:35:23:18: 15.
Further limit, the compound vitamin is prepared from vitamin A, vitamin D, vitamin K, vitamin E and vitamin B1Vitamin B2Vitamin B6Vitamin B12Nicotinamide, folic acid, pantothenic acid, vitamin C, biotin and carnitine; wherein, vitamin A, vitamin D, vitamin K, vitamin E, vitamin B1Vitamin B2Vitamin B6Vitamin B12The mass ratio of nicotinamide, folic acid, pantothenic acid, vitamin C, biotin and carnitine is 7.5:0.4:0.04:60:2:8:6:0.006:40:1.3:34:800:100: 2400.
Further limited, the compound mineral is composed of sodium, potassium, copper, magnesium, iron, zinc, manganese, calcium, phosphorus, iodine, chlorine and selenium; wherein the mass ratio of sodium, potassium, copper, magnesium, iron, zinc, manganese, calcium, phosphorus, iodine, chlorine and selenium is 3841:8213:5.71:859:114:111:0.43:7430:4290:1.86:82130: 0.17.
Further defined, the nucleotides consist of disodium 5 '-uridylate, adenosine 5' -monophosphate, disodium 5 '-inosinate, and disodium 5' -guanylate; wherein the mass ratio of the disodium 5 '-uridylate, the adenosine 5' -monophosphate, the disodium 5 '-inosinate and the disodium 5' -guanylate is 1:2:1: 2.
Further defined, the mass ratio of the vitamin A to the vitamin D in the cod liver oil is 10: 1.
Further, the mass ratio of whey protein contained in the raw milk and the skim milk to casein contained in the raw milk and the skim milk is 1.5-2.5: 1.
The invention also provides a preparation method of the newborn formula liquid milk, which comprises the following steps:
(1) filtering raw milk;
(2) adding the filtered raw milk, skim milk, whey protein powder, desalted whey powder, lactose, compound mineral nucleotide and lactoferrin into distilled water, and preheating to 70-90 ℃ to obtain a water-soluble ingredient;
(3) adding compound vitamins, beta-carotene, soybean lecithin, cod liver oil and mono-diglycerol fatty acid ester into compound vegetable oil, and heating to 60-80 ℃ for dissolving to obtain a fat-soluble ingredient;
(4) mixing the water-soluble ingredients in the step (2) and the fat-soluble ingredients in the step (3) and fixing the volume;
(5) homogenizing the material with constant volume in the step (4) at high pressure, wherein the homogenizing pressure is 25-40 MPa;
(6) and then carrying out high-pressure sterilization at the temperature of 105-110 ℃ for 8-10 min, and cooling to obtain a finished product.
Further, the pressure for homogenizing under high pressure in the step (5) is 30 MPa.
Further defined, the autoclaving conditions of step (6) are: the temperature is 105 ℃ and the time is 8 min.
Further defined, the autoclaving in step (6) is in-vial sterilization.
Further defined, the preheating temperature in the step (2) is 85 ℃.
Further defined, the heating temperature in the step (2) is 80 ℃.
The invention has the beneficial effects that:
1. the liquid milk with the formula for the newborn does not need to be mixed, and is convenient to eat, uniform in concentration, sanitary and safe compared with the traditional milk powder with the formula for the newborn.
2. The ratio of the whey protein to the casein in the liquid milk in the formula of the newborn is 1.5-2.5:1, so that the burden of the kidney is reduced, and the liquid milk is beneficial to absorption by the newborn.
3. The skim milk is added into the liquid milk in the formula of the newborn provided by the invention to replace the traditional skim milk powder, so that the skim milk retains more original nutrient substances in the milk compared with the skim milk powder.
4. The liquid milk in the formula for the newborn is added with the skim milk and is filled with the compound vegetable oil, so that the proportion of healthier saturated fatty acid and unsaturated fatty acid is ensured, the digestion and absorption are promoted, and the constipation of the newborn is reduced.
5. The liquid milk in the formula for the newborn is added with nucleotide to promote the growth of gastrointestinal tracts and improve the immunity.
6. The liquid milk of the formula for the newborn is added with the lactoferrin, and the lactoferrin can regulate the running and storage of iron ions in a body, promote the proliferation of red blood cells, promote the growth of bones, promote the proliferation and differentiation of epithelial cells of small intestines and regulate the immune function of an organism.
7. The liquid milk in the formula for the newborn is added with the beta-carotene, so that intestinal peristalsis of the newborn is promoted, constipation is reduced, and immunity of an organism is enhanced.
8. The cod liver oil is added into the liquid milk in the formula for the neonate, and the liquid milk is rich in vitamin A, vitamin D and unsaturated fatty acid, wherein the ratio of the vitamin A to the vitamin D is 10:1, nutrient substances in raw materials are not damaged, the liquid milk is beneficial to digestive absorption of the neonate, and the immunity is improved.
9. According to the invention, an autoclave is used for in-bottle sterilization, the sterilization temperature is 105-110 ℃, the sterilization time is 8-10 min, the sterilization method is lower than the traditional in-bottle sterilization temperature, the sterilization time is shortened, and more nutritional ingredients of the liquid milk in the formula of the newborn are kept under the condition of ensuring safety.
Detailed Description
The present invention will be further described with reference to the following specific examples, but the present invention is not limited to these examples.
The main raw materials and experimental equipment used in the following examples can be purchased from commercial sources, if not specifically indicated:
(1) the main raw materials are as follows: fresh raw milk, skim milk, compound vegetable oil, whey protein powder, desalted whey powder, lactose, compound vitamins, compound minerals, nucleotide, lactoferrin, beta-carotene, cod liver oil, soybean lecithin and monoglyceride and diglyceride fatty acid ester; wherein:
the compound vegetable oil consists of soybean oil, corn oil, palm oil, linseed oil and sunflower seed oil, wherein the mass ratio of the soybean oil to the corn oil to the palm oil to the linseed oil to the sunflower seed oil is 6:35:23:18: 15;
the compound vitamin is prepared from vitamin A, vitamin D, vitamin K, vitamin E, and vitamin B1Vitamin B2Vitamin B6Vitamin B12Nicotinamide, folic acid, pantothenic acid, vitamin C, biotin and carnitine, vitamin A, vitamin D, vitamin K, vitamin E, and vitamin B1Vitamin B2Vitamin B6Vitamin B12The mass ratio of nicotinamide, folic acid, pantothenic acid, vitamin C, biotin and carnitine is 7.5:0.4:0.04:60:2:8:6:0.006:40:1.3:34:800:100: 2400.
The compound mineral substance is composed of sodium, potassium, copper, magnesium, ferrum, zinc, manganese, calcium, phosphorus, iodine, chlorine and selenium; wherein the mass ratio of sodium, potassium, copper, magnesium, iron, zinc, manganese, calcium, phosphorus, iodine, chlorine and selenium is 3841:8213:5.71:859:114:111:0.43:7430:4290:1.86:82130: 0.17;
the mass ratio of the vitamin A to the vitamin D in the cod liver oil is 10: 1;
the nucleotide comprises disodium 5' -uridylate, adenosine 5' -monophosphate, disodium 5' -inosinate and disodium 5' -guanylate, wherein the mass ratio of the disodium 5' -uridylate to the adenosine 5' -monophosphate to the disodium 5' -inosinate is 1:2:1: 2.
The mass ratio of whey protein contained in raw milk and skim milk to casein contained in the raw milk and skim milk is 1.5-2.5: 1.
(2) Experimental equipment: an electromagnetic oven, a milk fat separator, a thermometer, an electronic analytical balance, a stirrer, a homogenizer and an autoclave.
The newborn formula liquid milk of the present invention and the preparation method thereof are described in detail below.
Example 1. preparation of newborn formula liquid milk.
The embodiment provides a newborn formula liquid milk, wherein each 1000L of the formula liquid milk is prepared from the following raw materials in parts by weight: 114.4kg of fresh raw milk, 114.4kg of skim milk, 29.7kg of compound vegetable oil, 6.5kg of whey protein powder, 58.5kg of desalted whey powder, 13.67kg of lactose, 0.14kg of compound vitamin, 0.2kg of compound mineral substance, 0.09kg of nucleotide, 0.05kg of lactoferrin, 0.000375kg of beta-carotene, 2.8L of cod liver oil, 0.5kg of soybean lecithin, 0.3kg of monoglyceride and diglyceride fatty acid ester, and the dry matter content of the liquid milk of the newborn formula is 13.95%.
The preparation method of the newborn formula liquid milk comprises the following steps:
(1) filtering fresh raw milk: filtering fresh raw milk by using double-layer gauze, and filtering out some impurities;
(2) adding the filtered fresh raw milk, skim milk, whey protein powder, desalted whey powder, lactose, compound mineral substances, nucleotide and lactoferrin into distilled water, and preheating to 85 ℃ to obtain a water-soluble ingredient;
(3) adding compound vitamins, beta-carotene, soybean lecithin, cod liver oil and mono-diglycerol fatty acid ester into compound vegetable oil, heating in water bath to 80 ℃ to completely dissolve the compound vegetable oil to obtain a fat-soluble ingredient;
(4) mixing the water-soluble ingredients obtained in the step (2) and the fat-soluble ingredients obtained in the step (3), fixing the volume, and uniformly stirring by using a force-increasing stirrer;
(5) homogenizing the material with constant volume under high pressure of 30 MPa;
(6) and (3) filling the homogenized material into a glass bottle, tightly covering the glass bottle, and finally sterilizing in an autoclave at the sterilization temperature of 105 ℃ for 8 min.
The liquid milk with the formula for the neonate prepared by the embodiment can meet the nutritional requirements of the neonate, can be directly drunk without being mixed, has good uniformity, is safe and sanitary, and is beneficial to digestive absorption and brain nerve development of the neonate.
Example 2 this example differs from example 1 in that: every 1000L of formula liquid milk is prepared from the following raw materials by weight: 165kg of fresh raw milk, 72kg of skim milk, 27.8kg of compound vegetable oil, 7.0kg of whey protein powder, 61.8Kgkg of desalted whey powder, 18.08kg of lactose, 0.19kg of compound vitamin, 0.25kg of compound mineral, 0.09kg of nucleotide, 0.1kg of lactoferrin, 0.0004kg of beta-carotene, 2.9L of cod liver oil, 0.5kg of soybean lecithin and 0.4kg of monoglyceride and diglyceride fatty acid ester. The preparation method is the same as example 1.
The liquid milk with the formula for the neonate prepared by the embodiment can meet the nutritional requirements of the neonate, can be directly drunk without being mixed, has good uniformity, is safe and sanitary, and is beneficial to digestive absorption and brain nerve development of the neonate.
Example 3 this example differs from example 1 in that: every 1000L of formula liquid milk is prepared from the following raw materials by weight: 220.3kg of fresh raw milk, 39.16kg of skim milk, 25.81kg of compound vegetable oil, 6.5kg of whey protein powder, 59kg of desalted whey powder, 13.67kg of lactose, 0.14kg of compound vitamin, 0.2kg of compound mineral, 0.09kg of nucleotide, 0.05kg of lactoferrin, 0.000375kg of beta-carotene, 2.8L of cod liver oil, 0.5kg of soybean lecithin and 0.5kg of monoglyceride and diglyceride fatty acid ester. The preparation method is the same as example 1.
The liquid milk with the formula for the neonate prepared by the embodiment can meet the nutritional requirements of the neonate, can be directly drunk without being mixed, has good uniformity, is safe and sanitary, and is beneficial to digestive absorption and brain nerve development of the neonate.
Example 4. example 1 was repeated, differing from example 1 in that the pressure for high-pressure homogenization in the liquid milk production process was 25MPa, the temperature for autoclaving was 110 c, and the time was 8 min.
Example 5. example 1 was repeated, differing from example 1 in that the pressure for high-pressure homogenization in the liquid milk production process was 40MPa, and the temperature for autoclaving was 105 c for 10 min.
To demonstrate the effects that can be obtained by the present invention, the following experiments were carried out:
1. sensory evaluation and storage experiments were conducted using the newborn formula liquid milk prepared in examples 1 to 3 to show that the newborn formula liquid milk has good homogeneity, a creamy flavor, and good storage stability.
The newborn formula liquid milk prepared in the following examples 1 to 3 was expressed in the experiment as a low dose group (added amount of raw milk is 114.4kg/1000L), a medium dose group (added amount of raw milk is 165kg/1000L), and a high dose group (added amount of raw milk is 220.3 kg/1000L); examples 4-5 the resulting newborn formula liquid milk prepared was expressed in the experimental group as a low pressure homogenization group (homogenization pressure of 25MPa) and a high pressure homogenization group (homogenization pressure of 40MPa), respectively.
1) Sensory evaluation: selecting 10 professionals with dairy product expertise and receiving sensory evaluation training for sensory evaluation. The grading standard comprises taste, smell, tissue state and color, and the proportion of the taste, the smell, the tissue state and the color is respectively 60, 30 and 10 for sensory grading.
TABLE 1 sensory evaluation chart
Single item score: when calculating the score, one of the highest score and the lowest score should be removed from the total singles scores. The calculation is carried out according to the following formula, and the result is an integer. The singleton score is the sum of the remaining singleton scores/(assessor-2).
Total points are as follows: when calculating the score, one highest score and one lowest score should be removed from the total score. Calculated according to the following formula. The result is an integer. Total score is the sum of remaining total scores/(assessor number-2).
The following table is the sensory evaluation results:
TABLE 2 examples 1-3 sensory evaluation Total score
| Experimental group | Total score |
| Example 1 | 89 |
| Example 2 | 92 |
| Example 3 | 98 |
According to table 2, it can be found that when fresh raw milk is added in the high dose group, the sensory evaluation score of the liquid milk in the formula of the newborn baby is 98 points at most, and the color, the taste and the tissue state of the product are more suitable for the consumers and the newborn babies compared with the low dose group and the high dose group.
Table 3 examples 4-5 sensory evaluation Total points
| Experimental group | Total score |
| Example 4 | 86 |
| Example 5 | 95 |
According to table 3, it can be found that when the homogenization pressure is high pressure homogenization, the sensory evaluation score of the liquid milk in the newborn formula is 95 points at the maximum, and the color and the tissue state of the product are more suitable for the consumers and the newborns compared with the low pressure homogenization group.
2) Storage experiment
(1) Experimental Material
Experimental materials: selecting low-dose group, medium-dose group, high-dose group, low-pressure homogenizing group, high-pressure homogenizing group, respectively 40 bottles, storing at 4 deg.C, 25 deg.C, 40 deg.C, indoor relative humidity RH ═ 32% + -2%, storing for 180 days, and randomly selecting one bottle every 30 days for sensory evaluation.
Low dose group-example 1 (1000L): 114.4kg of fresh raw milk, 114.4kg of skim milk, 29.7kg of compound vegetable oil, 6.5kg of whey protein powder, 58.5kg of desalted whey powder, 13.67kg of lactose, 0.14kg of compound vitamin, 0.2kg of compound mineral substance, 0.09kg of nucleotide, 0.05kg of lactoferrin, 0.000375kg of beta-carotene, 2.8L of cod liver oil, 0.5kg of soybean lecithin and 0.3kg of monoglyceride and diglyceride fatty acid ester.
Medium dose group-example 2 (1000L): 165Kg of fresh raw milk, 72Kg of skim milk, 27.8Kg of compound vegetable oil, 7.0Kg of whey protein powder, 61.8Kg of desalted whey powder, 18.08Kg of lactose, 0.19Kg of compound vitamin, 0.25Kg of compound mineral, 0.09Kg of nucleotide, 0.1Kg of lactoferrin, 0.0004Kg of beta-carotene, 2.9L of cod liver oil, 0.5Kg of soybean lecithin and 0.4Kg of monoglyceride and diglyceride fatty acid ester.
High dose group-example 3 (1000L): 220.3kg of fresh raw milk, 39.16kg of skim milk, 25.81kg of compound vegetable oil, 6.5kg of whey protein powder, 59kg of desalted whey powder, 13.67kg of lactose, 0.14kg of compound vitamin, 0.2kg of compound mineral, 0.09kg of nucleotide, 0.05kg of lactoferrin, 0.000375kg of beta-carotene, 2.8L of cod liver oil, 0.5kg of soybean lecithin and 0.5kg of monoglyceride and diglyceride fatty acid ester.
(2) Experimental methods and procedures
A low dose group; middle dose group; high dose group; fourthly, homogenizing under low pressure; high pressure homogenizing group with 30 bottles each. Each group of newborn formula liquid milk was randomly selected from 10 bottles, stored at 4 deg.C, 25 deg.C, and 40 deg.C for 180 days, and subjected to sensory evaluation, color difference and pH every 30 days. The sensory evaluation methods and criteria were as described above.
(3) And (3) analyzing an experimental result:
1) newborn formula liquid milk storage process sensory evaluation
TABLE 4 newborn formula liquid milk sensory score at 4℃
TABLE 5 newborn formula liquid milk sensory score at 25℃
TABLE 6 newborn formula liquid milk sensory score at 40℃
As can be seen from table 4, the sensory scores of the high-dose group, the medium-dose group and the low-dose group were less changed, the sensory score of the high-pressure homogenized group was the smallest, and the sensory score of the low-pressure homogenized group was higher when stored at 4 ℃ for 180 days. As can be seen from Table 5, the sensory scores of the three dose groups were significantly changed when stored at 25 ℃ for 180 days, and the sensory score of the high pressure homogenized group was higher than that of the low pressure homogenized group, while the sensory score of the high pressure homogenized group was minimal. As can be seen from table 6, the sensory scores of the three dose groups varied most when stored at 40 ℃, decreased as the storage time increased, the sensory score of the high dose group was the highest, and the sensory score of the high pressure homogenized group was higher than that of the low pressure homogenized group. As is clear from tables 4, 5 and 6, the sensory scores were less changed when stored at 4 ℃ and 25 ℃ for 180 days, while the sensory scores were greatly reduced when stored at 40 ℃. Therefore, storage at 25 ℃ can be selected, which is very little different from storage at 4 ℃ and reduces costs.
Claims (10)
1. The newborn formula liquid milk is characterized in that the raw materials of every 1000L of the newborn formula liquid milk comprise the following components: 114.4-220.3 kg of raw milk, 39.16-114.4 kg of skim milk, 25.81-29.7 kg of compound vegetable oil, 6.5-7.5 kg of whey protein powder, 58.5-65 kg of desalted whey powder, 13.67-22.5 kg of lactose, 0.14-0.25 kg of compound vitamin, 0.2-0.5 kg of compound mineral, 0.09-0.1 kg of nucleotide, 0.05-0.13 kg of lactoferrin, 0.000375-0.0005 kg of beta-carotene, 2.8-3L of cod liver oil, 0.5-0.52 kg of soybean lecithin and 0.3-0.5 kg of mono-diglycerol fatty acid ester; the dry matter content of the liquid milk in the formula of the newborn is 10-15%.
2. The newborn formula liquid milk according to claim 1, characterized in that the compounded vegetable oil consists of soybean oil, corn oil, palm oil, linseed oil and sunflower oil; wherein the mass ratio of the soybean oil to the corn oil to the palm oil to the linseed oil to the sunflower seed oil is 6:35:23:18: 15.
3. The newborn formula liquid milk according to claim 1, wherein the vitamin complex is vitamin A, vitamin D, vitamin K, vitamin E, vitamin B1Vitamin B2Vitamin B6Vitamin B12Nicotinamide, folic acid, pantothenic acid, vitamin C, biotin and carnitine; wherein, vitamin A, vitamin D, vitamin K, vitamin E, vitamin B1Vitamin B2Vitamin B6Vitamin B12The mass ratio of nicotinamide, folic acid, pantothenic acid, vitamin C, biotin and carnitine is 7.5:04:0.04:60:2:8:6:0.006:40:1.3:34:800:100: 2400.
4. The newborn formula liquid milk according to claim 1, wherein the compound minerals are composed of sodium, potassium, copper, magnesium, iron, zinc, manganese, calcium, phosphorus, iodine, chlorine and selenium; wherein the mass ratio of sodium, potassium, copper, magnesium, iron, zinc, manganese, calcium, phosphorus, iodine, chlorine and selenium is 3841:8213:5.71:859:114:111:0.43:7430:4290:1.86:82130: 0.17.
5. The newborn formula liquid milk according to claim 1, wherein the nucleotides consist of disodium 5 '-uridylate, adenosine 5' -monophosphate, disodium 5 '-inosinate, and disodium 5' -guanylate; wherein the mass ratio of the disodium 5 '-uridylate, the adenosine 5' -monophosphate, the disodium 5 '-inosinate and the disodium 5' -guanylate is 1:2:1: 2.
6. The newborn formula liquid milk according to claim 1, characterized in that the mass ratio of vitamin A and vitamin D in the cod liver oil is 10: 1.
7. The newborn formula liquid milk according to claim 1, wherein the mass ratio of whey protein contained to casein contained in the raw milk and skim milk is 1.5-2.5: 1.
8. The method for preparing a newborn formula liquid milk according to any one of claims 1 to 7, comprising the steps of:
(1) filtering raw milk;
(2) adding the filtered raw milk, skim milk, whey protein powder, desalted whey powder, lactose, compound mineral substances, nucleotide and lactoferrin into distilled water, and preheating to 70-90 ℃ to obtain a water-soluble ingredient;
(3) adding compound vitamins, beta-carotene, soybean lecithin, cod liver oil and mono-diglycerol fatty acid ester into compound vegetable oil, and heating to 60-80 ℃ for dissolving to obtain a fat-soluble ingredient;
(4) mixing the water-soluble ingredients in the step (2) and the fat-soluble ingredients in the step (3) and fixing the volume;
(5) homogenizing the material with constant volume in the step (4) at high pressure, wherein the homogenizing pressure is 25-40 Mpa;
(6) and then carrying out high-pressure sterilization at the temperature of 105-110 ℃ for 8-10 min, and cooling to obtain a finished product.
9. The method according to claim 8, wherein the high-pressure homogenization pressure in the step (5) is 30 MPa.
10. The method of claim 8, wherein the autoclaving conditions of step (6) are: the temperature is 105 ℃ and the time is 8 min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911098503.6A CN112841310A (en) | 2019-11-12 | 2019-11-12 | Newborn formula liquid milk and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911098503.6A CN112841310A (en) | 2019-11-12 | 2019-11-12 | Newborn formula liquid milk and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112841310A true CN112841310A (en) | 2021-05-28 |
Family
ID=75984430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911098503.6A Pending CN112841310A (en) | 2019-11-12 | 2019-11-12 | Newborn formula liquid milk and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112841310A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114766552A (en) * | 2022-05-10 | 2022-07-22 | 黑龙江辰鹰乳业有限公司 | Formula liquid milk suitable for 6-12 month babies and preparation method thereof |
| CN115669730A (en) * | 2022-10-31 | 2023-02-03 | 黑龙江辰鹰乳业有限公司 | Formula liquid milk suitable for 0-6 month babies and preparation method thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101233873A (en) * | 2008-02-02 | 2008-08-06 | 内蒙古蒙牛乳业（集团）股份有限公司 | Liquid state milk suitable for baby from newborn to six months old |
| CN101427789A (en) * | 2008-07-09 | 2009-05-13 | 内蒙古蒙牛乳业（集团）股份有限公司 | Liquid milk with additive nucleotide suitable for baby of 12 to 36 months old |
| CN102283289A (en) * | 2011-09-15 | 2011-12-21 | 澳优乳业（中国）有限公司 | Anti-inflaming infant formula milk powder and preparation process thereof |
| CN102511557A (en) * | 2011-12-29 | 2012-06-27 | 内蒙古伊利实业集团股份有限公司 | Liquid infant milk for newborn to six-month-old infant and production method thereof |
| CN108902322A (en) * | 2018-06-28 | 2018-11-30 | 湖南艾达伦科技有限公司 | A kind of peanut milk and preparation method |
| CN108967545A (en) * | 2018-06-28 | 2018-12-11 | 湖南艾达伦科技有限公司 | A kind of peanut and walnut milk and preparation method |
| CN110403022A (en) * | 2018-04-28 | 2019-11-05 | 内蒙古乳业技术研究院有限责任公司 | One kind being suitable for 0 ~ 12 month ready-to-feed infant milk and preparation method thereof |
-
2019
- 2019-11-12 CN CN201911098503.6A patent/CN112841310A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101233873A (en) * | 2008-02-02 | 2008-08-06 | 内蒙古蒙牛乳业（集团）股份有限公司 | Liquid state milk suitable for baby from newborn to six months old |
| CN101427789A (en) * | 2008-07-09 | 2009-05-13 | 内蒙古蒙牛乳业（集团）股份有限公司 | Liquid milk with additive nucleotide suitable for baby of 12 to 36 months old |
| CN102283289A (en) * | 2011-09-15 | 2011-12-21 | 澳优乳业（中国）有限公司 | Anti-inflaming infant formula milk powder and preparation process thereof |
| CN102511557A (en) * | 2011-12-29 | 2012-06-27 | 内蒙古伊利实业集团股份有限公司 | Liquid infant milk for newborn to six-month-old infant and production method thereof |
| CN110403022A (en) * | 2018-04-28 | 2019-11-05 | 内蒙古乳业技术研究院有限责任公司 | One kind being suitable for 0 ~ 12 month ready-to-feed infant milk and preparation method thereof |
| CN108902322A (en) * | 2018-06-28 | 2018-11-30 | 湖南艾达伦科技有限公司 | A kind of peanut milk and preparation method |
| CN108967545A (en) * | 2018-06-28 | 2018-12-11 | 湖南艾达伦科技有限公司 | A kind of peanut and walnut milk and preparation method |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114766552A (en) * | 2022-05-10 | 2022-07-22 | 黑龙江辰鹰乳业有限公司 | Formula liquid milk suitable for 6-12 month babies and preparation method thereof |
| CN115669730A (en) * | 2022-10-31 | 2023-02-03 | 黑龙江辰鹰乳业有限公司 | Formula liquid milk suitable for 0-6 month babies and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101744054A (en) | Infant formula milk powder | |
| CN102422900A (en) | Formula milk powder for promoting absorption of fatty acid and calcium and preparation method thereof | |
| CN105533696A (en) | Powder type total-nutrient formula food for patients suffering from tumors | |
| CN102429307A (en) | Low-calorie and total-nutrient beverage and preparation method thereof | |
| CN108013143A (en) | One kind strengthens the formula milk of 12 ~ 36 months infant's gastrointestinal functions | |
| CN104982533A (en) | Formula milk powder for enhancing immunity of infants and preparation method | |
| CN102550677A (en) | Liquid dairy product with health-care function on middle and old-aged people and production method for liquid dairy product | |
| CN112841310A (en) | Newborn formula liquid milk and preparation method thereof | |
| CN103564262B (en) | Hog grower feed | |
| CN114766552A (en) | Formula liquid milk suitable for 6-12 month babies and preparation method thereof | |
| EA011075B1 (en) | Dry powdered milk formula | |
| CN106234797A (en) | A kind of herbage diet producing high linolenic, linoleic acid Carnis Sus domestica | |
| CN109156530A (en) | A kind of diatery supplement nutrition packet and its production technology | |
| CN1907050A (en) | Red date sheep milk powder and method for making same | |
| CN107927198A (en) | One kind drinks milk powder and preparation method thereof for premature | |
| RU2425577C1 (en) | Soft cheese production method | |
| WO2019198092A1 (en) | Spirulina infused gummies and method to prepare thereof | |
| CN105053213A (en) | Milk powder capable of improving infant's immunity and production method thereof | |
| CN104782769A (en) | High-nutritive peanut milk production method | |
| CN108432879A (en) | A kind of complex function Sourbean milk that can remove beany flavor | |
| RU2279231C1 (en) | Composition based on meat for production of food products for early age children | |
| CN113729211A (en) | Composition and preparation method and application thereof | |
| US20210037854A1 (en) | Eggs rich in nutrients of alpha-linolenic acid and dha, breeding method of laying hens, and feed additive | |
| CN109845826A (en) | A kind of infant milk powder for simulating breast milk fatty acids structure and composition | |
| CN105613958A (en) | Method for producing magnesium-enriched eggs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210528 |
|
| RJ01 | Rejection of invention patent application after publication |